drugset / Trial / NCT05064332
A Study To Estimate The Effect of PF-06650833 On The Pharmacokinetics (PK) of Oral Contraceptive (OC)
Non-randomizedSequentialOpen-labelBasic science
Summary
This is a Phase 1, open label, fixed sequence study of the effect of multiple dose PF-06650833 on single dose OC PK in healthy female subjects.
Timeline
- Start
- 2021-10-08
- Primary completion
- 2021-12-16
- Completion
- 2021-12-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ZIMLOVISERTIB | Small molecule | 400 mg | Oral |
| Subject | ethinyl estradiol | Small molecule | 30 ug | Oral |
| Subject | levonogestrel | Unknown | 150 ug | Oral |
Indications
No indication recorded.